RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Joe Ramos to Intracellular Signaling Peptides and Proteins

This is a "connection" page, showing publications Joe Ramos has written about Intracellular Signaling Peptides and Proteins.
  1. Sulzmaier F, Opoku-Ansah J, Ramos JW. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases. 2012 Jul-Sep; 3(3):173-7.
    View in: PubMed
    Score: 0.386
  2. Gawecka JE, Geerts D, Koster J, Caliva MJ, Sulzmaier FJ, Opoku-Ansah J, Wada RK, Bachmann AS, Ramos JW. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer. 2012 Oct 01; 131(7):1556-68.
    View in: PubMed
    Score: 0.376
  3. Sulzmaier FJ, Valmiki MK, Nelson DA, Caliva MJ, Geerts D, Matter ML, White EP, Ramos JW. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene. 2012 Jul 26; 31(30):3547-60.
    View in: PubMed
    Score: 0.371
  4. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19837-42.
    View in: PubMed
    Score: 0.282
  5. Renault-Mihara F, Beuvon F, Iturrioz X, Canton B, De Bouard S, L?onard N, Mouhamad S, Sharif A, Ramos JW, Junier MP, Chneiweiss H. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell. 2006 Dec; 17(12):5141-52.
    View in: PubMed
    Score: 0.065
  6. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005 Sep 15; 390(Pt 3):729-35.
    View in: PubMed
    Score: 0.060
  7. Sur R, Ramos JW. Vanishin is a novel ubiquitinylated death-effector domain protein that blocks ERK activation. Biochem J. 2005 Apr 15; 387(Pt 2):315-24.
    View in: PubMed
    Score: 0.059
  8. Ramos JW. Cancer research center hotline: PEA-15 phosphoprotein: a potential cancer drug target. Hawaii Med J. 2005 Mar; 64(3):77-80.
    View in: PubMed
    Score: 0.058
  9. Vaidyanathan H, Ramos JW. RSK2 activity is regulated by its interaction with PEA-15. J Biol Chem. 2003 Aug 22; 278(34):32367-72.
    View in: PubMed
    Score: 0.052
  10. Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H, Ginsberg MH. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell. 2000 Sep; 11(9):2863-72.
    View in: PubMed
    Score: 0.043
  11. Greig FH, Kennedy S, Gibson G, Ramos JW, Nixon GF. PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia. J Am Heart Assoc. 2017 Sep 11; 6(9).
    View in: PubMed
    Score: 0.035
  12. Hunter I, Mascall KS, Ramos JW, Nixon GF. A phospholipase C?1-activated pathway regulates transcription in human vascular smooth muscle cells. Cardiovasc Res. 2011 Jun 01; 90(3):557-64.
    View in: PubMed
    Score: 0.022
  13. Zhang Y, Redina O, Altshuller YM, Yamazaki M, Ramos J, Chneiweiss H, Kanaho Y, Frohman MA. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem. 2000 Nov 10; 275(45):35224-32.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support